Abstract
Acrosoxacin was given as a single 300 mg oral dose to 105 patients with acute gonorrhoea. Of the 100 patients followed completely there was a 93% cure rate and 33% of men developed postgonococcal urethritis (PGU). This compared with a 97% cure and 30% PGU with 2 megaunits penicillin. The in vitro activity of acrosoxacin in Nottingham against strains of Neisseria gonorrhoeae showed that it was a highly active agent with 90070 of strains inhibited by a concentration of 0-03 mg/l.
| Original language | English |
|---|---|
| Pages (from-to) | 242-244 |
| Number of pages | 3 |
| Journal | Sexually Transmitted Infections |
| Volume | 59 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1983 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Acrosoxacin in the treatment of uncomplicated gonorrhoea'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver